Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544242 · ClinicalTrials.gov registry record · Phase 2
Nitrite Infusion in Islet Cell Transplantation
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT03544242 is a Phase 2 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 4 participants.
The verdict
NCT03544242, a Phase 2 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study seeks to investigate the effects of administering nitrite to pancreatic islet cells that have been removed from a patient for autotransplantation.
Interventions
- OTHER Control
- DRUG Pre-Isolation Infusion
- DRUG Post-Isolation Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-05-07 |
| Est. Completion | 2019-06-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03544242
The ClinicalTrials.gov registry entry for NCT03544242 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT03544242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03544242 about?
NCT03544242 is a clinical study titled "Nitrite Infusion in Islet Cell Transplantation". This study seeks to investigate the effects of administering nitrite to pancreatic islet cells that have been removed from a patient for autotransplantation.
What is the current status of trial NCT03544242?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2017-05-07. Estimated completion is 2019-06-27.
What interventions are being tested in trial NCT03544242?
The interventions under investigation include: Control (OTHER), Pre-Isolation Infusion (DRUG), Post-Isolation Infusion (DRUG).
Who is sponsoring clinical trial NCT03544242?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.